Abir Absar, PhD, is currently the Senior Director and Global Regulatory Franchise Head at AstraZeneca, where they develop and execute global regulatory strategies for an immunology franchise. With a background as a Reviewer at the US FDA from 2014 to 2020, Abir has extensive experience in regulatory processes for drugs and biologics, including pivotal roles in the approval of several notable products. Abir holds a PhD in Pharmaceutical Sciences from Texas Tech University Health Sciences Center, completed in 2014.
This person is not in any teams
This person is not in any offices